Czech National Bank Buys 16,791 Shares of CVS Health Co. (NYSE:CVS)

Czech National Bank boosted its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 6.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 289,645 shares of the pharmacy operator's stock after purchasing an additional 16,791 shares during the quarter. Czech National Bank's holdings in CVS Health were worth $19,623,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the business. McIlrath & Eck LLC grew its holdings in CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 174 shares during the period. Coppell Advisory Solutions LLC boosted its holdings in shares of CVS Health by 17.3% in the 4th quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock valued at $56,000 after purchasing an additional 189 shares during the last quarter. EagleClaw Capital Managment LLC grew its stake in shares of CVS Health by 3.4% during the 4th quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator's stock valued at $275,000 after buying an additional 200 shares during the period. Manchester Capital Management LLC increased its holdings in shares of CVS Health by 4.8% during the 4th quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator's stock worth $200,000 after buying an additional 204 shares during the last quarter. Finally, Angeles Investment Advisors LLC boosted its holdings in CVS Health by 3.7% in the fourth quarter. Angeles Investment Advisors LLC now owns 5,706 shares of the pharmacy operator's stock valued at $256,000 after acquiring an additional 204 shares during the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of research reports. Leerink Partnrs upgraded CVS Health from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 12th. Wolfe Research raised their price target on shares of CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a report on Tuesday, February 11th. Cantor Fitzgerald raised shares of CVS Health from a "neutral" rating to an "overweight" rating in a research note on Wednesday, February 12th. Barclays decreased their price target on shares of CVS Health from $82.00 to $79.00 and set an "overweight" rating for the company in a research report on Monday. Finally, UBS Group upped their target price on CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a research report on Friday, May 2nd. Two research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $74.75.

CVS Health Stock Performance

Shares of NYSE:CVS traded down $0.52 during trading on Thursday, hitting $63.05. 6,599,235 shares of the company traded hands, compared to its average volume of 11,115,336. CVS Health Co. has a one year low of $43.56 and a one year high of $72.51. The stock has a market capitalization of $79.76 billion, a price-to-earnings ratio of 17.23, a PEG ratio of 0.98 and a beta of 0.56. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The business's fifty day moving average is $65.30 and its 200-day moving average is $59.84.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The business had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. During the same quarter in the prior year, the firm posted $1.31 earnings per share. The company's revenue was up 7.0% on a year-over-year basis. As a group, equities analysts predict that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.22%. The ex-dividend date was Tuesday, April 22nd. CVS Health's dividend payout ratio is 63.48%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.